Terms: = Lung cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Prognosis
20 results:
1. High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/hk2 axis.
Xiong X; Zhang L; Zang B; Xu D; Chen C; Dong G; Xia W; Wu Y
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960858
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq.
Zhang Y; Shi J; Luo J; Liu C; Zhu L
Clin Transl Oncol; 2023 Jun; 25(6):1844-1855. PubMed ID: 36692643
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of
Zhou Y; Yuan Y; Zhang Q; Shen Y; Chen W; Yan L
Ann Clin Lab Sci; 2022 Sep; 52(5):753-762. PubMed ID: 36261188
[TBL] [Abstract] [Full Text] [Related]
4. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract] [Full Text] [Related]
5. The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/hk2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.
You Q; Wang J; Yu Y; Li F; Meng L; Chen M; Yang Q; Xu Z; Sun J; Zhuo W; Chen Z
Apoptosis; 2022 Dec; 27(11-12):883-898. PubMed ID: 35915188
[TBL] [Abstract] [Full Text] [Related]
6. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract] [Full Text] [Related]
7. Novel long non-coding RNA CYB561-5 promotes aerobic glycolysis and tumorigenesis by interacting with basigin in non-small cell lung cancer.
Li L; Li Z; Qu J; Wei X; Suo F; Xu J; Liu X; Chen C; Zheng S
J Cell Mol Med; 2022 Mar; 26(5):1402-1412. PubMed ID: 35064752
[TBL] [Abstract] [Full Text] [Related]
8. Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway.
Bing ZX; Zhang JQ; Wang GG; Wang YQ; Wang TG; Li DQ
Kaohsiung J Med Sci; 2021 Dec; 37(12):1027-1037. PubMed ID: 34405943
[TBL] [Abstract] [Full Text] [Related]
9. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract] [Full Text] [Related]
10. Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.
Yang L; Yan X; Chen J; Zhan Q; Hua Y; Xu S; Li Z; Wang Z; Dong Y; Zuo D; Xue M; Tang Y; Herschman HR; Lu S; Shi Q; Wei W
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836566
[TBL] [Abstract] [Full Text] [Related]
11. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells.
Hsu HS; Liu CC; Lin JH; Hsu TW; Hsu JW; Li AF; Hung SC
J Biomed Sci; 2020 Jan; 27(1):5. PubMed ID: 31928533
[TBL] [Abstract] [Full Text] [Related]
12. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract] [Full Text] [Related]
13. Human steroid sulfatase enhances aerobic glycolysis through induction of HIF1α and glycolytic enzymes.
Shin S; Kwon YJ; Ye DJ; Baek HS; Kwon TU; Kim D; Chun YJ
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2464-2474. PubMed ID: 31195119
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract] [Full Text] [Related]
15. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of microRNA-155 sensitizes lung cancer cells to irradiation via suppression of hk2-modulated glucose metabolism.
Lv X; Yao L; Zhang J; Han P; Li C
Mol Med Rep; 2016 Aug; 14(2):1332-8. PubMed ID: 27315591
[TBL] [Abstract] [Full Text] [Related]
17. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract] [Full Text] [Related]
18. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract] [Full Text] [Related]
19. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract] [Full Text] [Related]
20. Human tissue kallikreins: the cancer biomarker family.
Paliouras M; Borgono C; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
[TBL] [Abstract] [Full Text] [Related]
